Literature DB >> 19073060

Development and validation of HPLC method for determination of clotrimazole and its two degradation products in spray formulation.

Renata Hájková1, Hana Sklenárová, Ludmila Matysová, Petra Svecová, Petr Solich.   

Abstract

A novel simple isocratic HPLC method with UV detection for the determination of three compounds in spray solution (active component clotrimazole and two degradation products imidazole and (2-chlorophenyl)diphenylmethanol) using ibuprofen as an internal standard was developed and validated. The complications with different acido-basic properties of the analysed compounds in HPLC separation - while clotrimazole has pK(a) 4.7, imidazole has pK(a) 6.9 compared to relatively more acidic (2-chlorophenyl)diphenylmethanol - were finally overcome using a 3.5mum Zorbax((R)) SB-Phenyl column (75mmx4.6mm i.d., Agilent Technologies). The optimal mobile phase for separation of clotrimazole, degradation products imidazole and (2-chlorophenyl)diphenylmethanol and ibuprofen as internal standard consists of a mixture of acetonitrile and water (65:35, v/v) with pH* conditioned by phosphoric acid to 3.5. At a flow rate of 0.5mlmin(-1) and detection at 210nm, the total time of analysis was less than 6min. The method was applied for routine analysis (batch analysis and stability tests) in commercial spray solution.

Entities:  

Year:  2007        PMID: 19073060     DOI: 10.1016/j.talanta.2007.04.023

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  2 in total

1.  Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery.

Authors:  Fahima M Hashem; Dalia S Shaker; Mohamed Khalid Ghorab; Mohamed Nasr; Aliaa Ismail
Journal:  AAPS PharmSciTech       Date:  2011-07-02       Impact factor: 3.246

2.  Novel Spray Dried Glycerol 2-Phosphate Cross-Linked Chitosan Microparticulate Vaginal Delivery System-Development, Characterization and Cytotoxicity Studies.

Authors:  Emilia Szymańska; Marta Szekalska; Robert Czarnomysy; Zoran Lavrič; Stane Srčič; Wojciech Miltyk; Katarzyna Winnicka
Journal:  Mar Drugs       Date:  2016-09-28       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.